Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Maloney Michael T. 2. Date of Event Requiring Statement (Month/Day/Year) 02/27/2026 3. Issuer Name and Ticker or Trading Symbol TENET HEALTHCARE CORP [THC] (Last) (First) (Middle) 14201 DALLAS PARKWAY 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Corporate Development 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) DALLAS, TX 75254 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 101,990 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2018 February Performance Stock Options (Right to Buy)	02/28/2021	02/28/2028	Common Stock	18,876	$20.6	D
2019 February Performance Stock Options (Right to Buy)	02/24/2026	02/27/2029	Common Stock	18,682	$28.26	D
2024 February Restricted Stock Units	(1)	(1)	Common Stock(2)	3,737	(2)	D
2025 February Restricted Stock Units	(3)	(3)	Common Stock(2)	5,068	(2)	D
2026 February Restricted Stock Units	(4)	(4)	Common Stock(2)	5,013	(2)	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Maloney Michael T. 14201 DALLAS PARKWAY DALLAS, TX 75254			EVP, Corporate Development

Signatures

Chad J. Wiener, as Attorney-in-Fact for Michael T. Maloney		03/09/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Represents unvested February 2024 time-based restricted stock units that vest in full on February 28, 2027.
(2)	Restricted stock units are settled in shares of the Company's common stock upon vesting.
(3)	Represents unvested February 2025 time-based restricted stock units that vest in equal remaining increments on February 24, 2027, and February 24, 2028.
(4)	Represents unvested February 2026 time-based restricted stock units that vest in one-third increments on February 27, 2027, February 27, 2028, and February 27, 2029.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.